Colgate-PalmoliveCLEarnings & Financial Report
The Colgate-Palmolive Company, commonly known as Colgate-Palmolive, is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. The company specializes in the production, distribution, and provision of household, health care, personal care, and veterinary products.
Revenue
$4.9B
Gross Profit
$3.0B
Operating Profit
$1.1B
Net Profit
$738.0M
Gross Margin
60.3%
Operating Margin
21.5%
Net Margin
14.9%
YoY Growth
-0.1%
EPS
$0.89
Colgate-Palmolive Q4 FY2024 Financial Summary
Colgate-Palmolive reported revenue of $4.9B (down 0.1% YoY) for Q4 FY2024, with a net profit of $738.0M (up 2.8% YoY) (14.9% margin). Cost of goods sold was $2.0B, operating expenses totaled $1.9B.
Key Financial Metrics
| Total Revenue | $4.9B |
|---|---|
| Net Profit | $738.0M |
| Gross Margin | 60.3% |
| Operating Margin | 21.5% |
| Report Period | Q4 FY2024 |
Revenue Breakdown
Colgate-Palmolive Q4 FY2024 revenue of $4.9B breaks down across 3 segments, led by Other at $2.7B (54.5% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Other | $2.7B | 54.5% |
| Pet Nutrition | $1.1B | 23.1% |
| Oral Personal And Home Care | $1.1B | 22.4% |
Colgate-Palmolive Revenue by Segment — Quarterly Trend
Colgate-Palmolive revenue by segment across the last 4 reported quarters, showing how each business line (such as Other and Pet Nutrition) has evolved quarter over quarter.
| Segment | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|
| Other | — | $3.0B | $3.0B | $2.9B |
| Pet Nutrition | $1.2B | $1.2B | $1.1B | $1.2B |
| Oral Personal And Home Care | — | $1.0B | $999.0M | $1.0B |
Colgate-Palmolive Annual Revenue by Year
Colgate-Palmolive annual revenue history includes year-by-year totals (for example, 2025 revenue was $20.4B).
| Year | Annual Revenue |
|---|---|
| 2025 | $20.4B |
| 2024 | $20.1B |
| 2023 | $19.5B |
| 2022 | $18.0B |
Colgate-Palmolive Quarterly Revenue & Net Profit History
Colgate-Palmolive results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $5.3B | +8.4% | $646.0M | 12.1% |
| Q4 FY2025 | $5.2B | +5.8% | $-36.0M | -0.7% |
| Q3 FY2025 | $5.1B | +1.9% | $735.0M | 14.3% |
| Q2 FY2025 | $5.1B | +1.0% | $743.0M | 14.5% |
| Q1 FY2025 | $4.9B | -3.0% | $690.0M | 14.1% |
| Q4 FY2024 | $4.9B | -0.1% | $738.0M | 14.9% |
| Q3 FY2024 | $5.0B | +2.4% | $737.0M | 14.6% |
| Q2 FY2024 | $5.1B | +4.9% | $731.0M | 14.5% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.06B | $5.03B | $4.95B | $4.91B | $5.11B | $5.13B | $5.23B | $5.32B |
| YoY Growth | 4.9% | 2.4% | -0.1% | -3.0% | 1.0% | 1.9% | 5.8% | 8.4% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $16.48B | $16.77B | $16.05B | $16.65B | $17.47B | $17.51B | $16.33B | $16.61B |
| Liabilities | $16.00B | $15.94B | $15.50B | $15.91B | $16.42B | $16.27B | $15.96B | $16.12B |
| Equity | $123.0M | $435.0M | $212.0M | $363.0M | $702.0M | $856.0M | $54.0M | N/A |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $990.0M | $1.17B | $1.27B | $600.0M | $884.0M | $1.26B | $1.45B |